6 results found.

Tourette Disorder, or Tourette Syndrome Clinical Trial using placebo; extended-release guanfacine (Intuniv)

Yale University - Recruiting 6 years to 17 years.
- Guanfacine in Children With Tic Disorders: A Multi-site Study.
placebo; extended-release guanfacine (Intuniv)

Bipolar Disorder, Depression, Anxiety Disorders, Schizophrenia, T Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Brain Procurement for the Human Brain Collection Core.

Movement Disorder, Tourette Syndrome, or Healthy Volunteer Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 60 years.
- Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders.

Communication Disorder, Healthy, Stuttering, Tourette Syndrome, o Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 85 years.
- Multimodal Studies of Language Production and Comprehension in Normal Volunteers and Patients With Neurologically-Based Language Impairments.

Tic Disorder, or Tourette Syndrome Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 65 years.
- Understanding the Anatomy and Physiology of the Sensory Experience and Its Role in Generating Tics in Tourette Syndrome.

Tourette Syndrome Clinical Trial using AZD5213 and placebo

AstraZeneca - Recruiting 12 years to 17 years.
- A 6-month, Multicenter, Randomized, Safety, Tolerability, Pharmacokinetic, and Preliminary Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder.
AZD5213 and placebo